Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityNo recent work listed

Ding Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9149-4362; OpenAlex author ID A5100449516. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

  1. Study of the Mechanism by Which Curcumin Cooperates with Sestrin2 to Inhibit the Growth of Pancreatic Cancer. Co-author DOI 10.1155/2021/7362233↗
  2. KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway. Co-author DOI 10.2147/cmar.s243129↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongwei Sun · 1 shared paper, 2021 · strength 0.14
  2. Fubiao Ni · 1 shared paper, 2021 · strength 0.14
  3. Haotian Fu · 1 shared paper, 2021 · strength 0.14
  4. Yunfeng Shan · 1 shared paper, 2021 · strength 0.14
  5. Shengjie Dai · 1 shared paper, 2021 · strength 0.14
  6. Linxiao Sun · 1 shared paper, 2020 · strength 0.11
  7. Chenlei Zheng · 1 shared paper, 2020 · strength 0.11
  8. Bicheng Chen · 1 shared paper, 2020 · strength 0.11
  9. Cheng Wang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.